POLVET - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 119,507 | 163,741 | 404,508 | 423,192 | 510,838 | 953,165 | 404,658 | 356,334 |
| Profit before tax | -1,265 | -6,533 | - | - | - | 56,012 | - | - |
| Net profit | -1,265 | -6,533 | -3,061 | 11,905 | 17,643 | 48,101 | 5,315 | 13,961 |
| Equity | 191,643 | 121,559 | 118,498 | 130,403 | 148,046 | 196,147 | 201,462 | 215,423 |
| Liabilities | 114,418 | 132,282 | 140,093 | 126,622 | 130,418 | 101,100 | 78,489 | 218,769 |
| Non-current assets | 145,869 | 113,079 | 121,366 | 92,895 | 98,941 | 119,479 | 98,811 | 117,772 |
| Current assets | 160,192 | 140,762 | 105,937 | 128,276 | 140,689 | 177,768 | 181,140 | 308,827 |
| Total assets | 306,061 | 253,841 | 227,303 | 221,171 | 239,630 | 297,247 | 279,951 | 426,599 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 18,516 | - | - |
| Social insurance contributions | - | - | - | - | - | 3,258 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -50.9% | +37.0% | +147.0% | +4.6% | +20.7% | +86.6% | -57.5% | -11.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.4% | -2.6% | -1.3% | 5.4% | 7.4% | 16.2% | 1.9% | 3.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -0.7% | -5.4% | -2.6% | 9.1% | 11.9% | 24.5% | 2.6% | 6.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.1% | -4.0% | -0.8% | 2.8% | 3.5% | 5.0% | 1.3% | 3.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.1% | -4.0% | - | - | - | 5.9% | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 1.1 | 1.2 | 1.0 | 0.9 | 0.5 | 0.4 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 59,754 | 81,871 | 85,160 | 61,931 | 125,104 | 293,282 | 161,863 | 178,167 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
POLVET - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-23 | 378.60 |
| 2026-07-16 | 2026-07-17 | 378.60 |
| 2026-04-20 | 2026-04-22 | 0.70 |
| 2026-01-16 | 2026-01-20 | 0.36 |
| 2026-01-01 | 2026-01-05 | 0.27 |
| 2025-12-16 | 2025-12-30 | 0.27 |
| 2025-11-18 | 2025-12-04 | 0.18 |
| 2025-10-16 | 2025-11-05 | 0.09 |
| 2025-09-16 | 2025-10-05 | 0.09 |
| 2025-08-31 | 2025-09-02 | 1.40 |
| 2025-08-19 | 2025-08-29 | 1.40 |
| 2025-07-28 | 2025-08-17 | 1.31 |
| 2025-07-26 | 2025-07-27 | 0.18 |
| 2025-07-24 | 2025-07-25 | 1.31 |
| 2025-07-16 | 2025-07-23 | 0.18 |
| 2025-06-17 | 2025-07-13 | 0.09 |
| 2025-05-16 | 2025-05-25 | 379.36 |
| 2024-03-18 | 2024-03-24 | 532.81 |
| 2021-10-18 | 2021-10-20 | 705.79 |
POLVET - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-22 | 2026-04-27 | 0.22 |
| 2026-04-17 | 2026-04-21 | 83.59 |
| 2026-03-29 | 2026-04-16 | 0.3 |
| 2026-03-18 | 2026-03-18 | 83.21 |
| 2024-12-19 | 2024-12-28 | 0.77 |
| 2024-12-17 | 2024-12-18 | 47.7 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
POLVET, UAB (code 110837050) is a Private Limited Liability Company operating in wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €356.3K, down from €404.7K in 2024 and €953.2K in 2023, showing a clear two-year contraction in sales. Profitability also weakened over the period: net profit was €48.1K in 2023 and €5.3K in 2024, while no net profit figure is stated for 2025. The 2024 profit margin was 1.3%, compared with 5.0% in 2023, indicating softer earnings relative to turnover. Balance sheet size increased in 2025, with total assets rising to €426.6K from €280.0K a year earlier, supported by equity of €215.4K and liabilities of €218.8K. The equity ratio stood at 50.5% and debt-to-equity at 1.02, while asset turnover was 0.84x. Revenue per employee was €178.2K, suggesting solid productivity despite weaker sales momentum.